A detailed history of Martingale Asset Management L P transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 34,740 shares of ANIP stock, worth $1.96 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
34,740
Previous 21,021 65.26%
Holding current value
$1.96 Million
Previous $1.34 Million 54.86%
% of portfolio
0.05%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $745,353 - $901,612
13,719 Added 65.26%
34,740 $2.07 Million
Q2 2024

Aug 12, 2024

BUY
$58.53 - $68.82 $151,592 - $178,243
2,590 Added 14.05%
21,021 $1.34 Million
Q1 2024

May 14, 2024

BUY
$54.2 - $69.69 $76,476 - $98,332
1,411 Added 8.29%
18,431 $1.27 Million
Q3 2023

Nov 14, 2023

SELL
$50.28 - $64.61 $50 - $64
-1 Reduced 0.01%
17,020 $988,000
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $29,832 - $43,064
800 Added 4.93%
17,021 $916,000
Q4 2022

Feb 13, 2023

BUY
$31.9 - $41.95 $9,410 - $12,375
295 Added 1.85%
16,221 $652,000
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $92,473 - $117,831
3,100 Added 24.17%
15,926 $513,000
Q2 2022

Aug 11, 2022

BUY
$23.09 - $33.46 $58,117 - $84,218
2,517 Added 24.42%
12,826 $380,000
Q1 2022

May 12, 2022

BUY
$26.91 - $47.15 $21,554 - $37,767
801 Added 8.42%
10,309 $289,000
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $313,478 - $540,529
9,508 New
9,508 $438,000
Q4 2020

Feb 10, 2021

SELL
$23.69 - $31.47 $564,035 - $749,269
-23,809 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$26.38 - $33.1 $704,346 - $883,770
-26,700 Reduced 52.86%
23,809 $671,000
Q2 2020

Aug 10, 2020

SELL
$29.93 - $50.1 $119 - $200
-4 Reduced 0.01%
50,509 $1.63 Million
Q1 2020

May 11, 2020

BUY
$30.35 - $67.14 $312,635 - $691,609
10,301 Added 25.62%
50,513 $2.06 Million
Q4 2019

Feb 10, 2020

SELL
$55.65 - $79.83 $300,510 - $431,082
-5,400 Reduced 11.84%
40,212 $2.48 Million
Q3 2019

Nov 13, 2019

BUY
$64.7 - $85.39 $194,164 - $256,255
3,001 Added 7.04%
45,612 $3.32 Million
Q2 2019

Aug 13, 2019

BUY
$67.77 - $82.2 $1.05 Million - $1.27 Million
15,502 Added 57.18%
42,611 $0
Q1 2019

May 08, 2019

BUY
$45.83 - $70.54 $174,154 - $268,052
3,800 Added 16.3%
27,109 $0
Q4 2018

Feb 11, 2019

BUY
$41.17 - $56.44 $959,631 - $1.32 Million
23,309 New
23,309 $1.05 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.